Skip to main content
High RiskFDAfda-H-0048-2025OTHER

Topo Chico MINERAL WATER CARBONATED 16.9 FL OZ (500mL) Bottle UPC 0 21136 18061 9, Case UPC 0 21136 18062 6 MADE IN MEXICO BY: CIA. TOPO ...

Category
Units Affected
241
Recall Date
May 28, 2025
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0048-2025.

Pseudomonas in Mineral Water. The firm was notified by their distributor that product placed on hold was released and shipped to customers.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0048-2025.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact The Coca-cola Company or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-H-0048-2025.

The Coca-Cola Company

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

The Coca-cola Company Recall FAQ

The Coca-cola Company is the subject of a beverages safety report: Topo Chico MINERAL WATER CARBONATED 16.9 FL OZ (500mL) Bottle UPC 0 21136 18061 9, Case UPC 0 21136 18062 6 MADE IN MEXICO BY: CIA. TOPO .... The notice was published on May 28, 2025 by the U.S. Food and Drug Administration (FDA). Approximately 241 units are potentially affected.